Last reviewed · How we verify

NCT04711512

Responses to Physical Activity Messages Among Midlife Adults

Completed Last updated 28 April 2022
What this trial tests

trial testing Encouragement/Support in Exercise in 30 participants. Completed in 31 January 2022.

Timeline
8 April 2021
Primary endpoint
31 January 2022
31 January 2022

Quick facts

Lead sponsorRowan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date8 April 2021
Primary completion31 January 2022
Estimated completion31 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rowan University

Who can join

Adults 40 to 60, any sex, with Exercise or Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the short-term effects of physical activity promotion messages designed for midlife adults. These messages are designed to provide information and motivation for physical activity by engaging key social processes, such as social comparison (i.e., self-evaluations relative to others).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Digital, Social Micro-Interventions to Promote Physical Activity Among Midlife Adults With Elevated Cardiovascular Risk: An Ambulatory Feasibility Study With Momentary Randomization.
    Arigo D, Schumacher LM, Baga K, Mogle JA. · · 2024 · cited 4× · PMID 39454044 · DOI 10.1093/abm/kaae058

Verify or expand the search:

Other recruiting trials for Exercise

Currently open trials in the same condition.

Other Rowan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04711512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing